| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5555700 | Journal of the American Pharmacists Association | 2017 | 7 Pages |
Abstract
One in 4 patients recommended for osteoporosis pharmacotherapy declined treatment because they feared potential adverse effects, did not like taking medicine, or believed that the medication would not help their condition. Improved patient counseling on the potential adverse effects of osteoporosis treatment and the risk-benefit ratio for these medications may increase adherence.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Sylvie F. Hall, Stephanie W. Edmonds, Yiyue Lou, Peter Cram, Douglas W. Roblin, Kenneth G. Saag, Nicole C. Wright, Michael P. Jones, Fredric D. Wolinsky,